Nestle India Reports Rise in Quarterly Profit, Announces JV With Dr. Reddy's Laboratories
By Kosaku Narioka
Nestle India reported a rise in quarterly net profit on higher revenue and announced a new joint venture with Dr. Reddy's Laboratories.
The Indian unit of food and beverage company Nestle said Thursday that net profit rose 27% from a year earlier to 9.34 billion rupees ($112.1 million) for the three months ended March 31.
Revenue increased 9.0% from a year earlier to INR52.68 billion, thanks to broad-based sales growth.
Nestle India also said it agreed to set up a joint venture with Dr. Reddy's Laboratories to sell nutritional products by leveraging the pharmaceutical company's robust retail and distribution network.
Nestle India will have a call option to increase its stake in the JV to up to 60% after six years from 49% initially, it said.
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
April 25, 2024 06:32 ET (10:32 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Top-Performing Dividend Stocks of Q3 2024
-
33 Undervalued Stocks
-
Communication Services: Cable’s Broadband Dominance Isn’t as Strong as It Once Was
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities
-
Best- and Worst-Performing Stocks of Q3 2024
-
Top Stocks to Own From the Best Fund Managers
-
2 Cheap Stocks Top Managers Have Been Buying
-
The 10 Best Companies to Invest in Now